The Cooper Companies, Inc.

COO ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2009 FY2008
Revenue $1.08B $1.05B
Cost of Revenue $483.9M $437.3M
Gross Profit $596.5M $610.0M
Gross Margin 55.2% 58.2%
Operating Expenses
Research & Development $33.3M $35.5M
SG&A Expense $391.6M $429.3M
Operating Income $149.9M $127.0M
Operating Margin 13.9% 12.1%
Interest Expense $44.1M $53.0M
Pretax Income $114.8M $74.0M
Income Tax Expense $14.3M $10.0M
Net Income $100.5M $64.0M
Net Margin 9.3% 6.1%
EPS (Basic) $0.56 $0.36
EPS (Diluted) $0.55 $0.36
Shares Outstanding (Basic) 180.7M 180.0M
Shares Outstanding (Diluted) 181.9M 180.5M
Dividends Per Share — —
← Newer Page 3 of 3 Older →